Le Lézard
Classified in: Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Schlumberger Announces Second-Quarter 2022 Results Conference Call


Schlumberger Limited (NYSE:SLB) will hold a conference call on July 22, 2022 to discuss the results for the second quarter ending June 30, 2022.

The conference call is scheduled to begin at 9:30 am US Eastern time and a press release regarding the results will be issued at 7:00 am US Eastern time.

To access the conference call, listeners should contact the Conference Call Operator at +1 (844) 721-7241 within North America or +1 (409) 207-6955 outside of North America approximately 10 minutes prior to the start of the call and the access code is 8858313.

A webcast of the conference call will be broadcast simultaneously at www.slb.com/irwebcast on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until August 22, 2022, and can be accessed by dialing +1 (866) 207-1041 within North America or +1 (402) 970-0847 outside of North America and giving the access code 9508868.

About Schlumberger

Schlumberger (SLB: NYSE) is a technology company that partners with customers to access energy. Our people, representing over 160 nationalities, are providing leading digital solutions and deploying innovative technologies to enable performance and sustainability for the global energy industry. With expertise in more than 120 countries, we collaborate to create technology that unlocks access to energy for the benefit of all.

Find out more at www.slb.com


These press releases may also interest you

at 01:40
Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensorstm, has signed a license agreement with a new customer ? a top-10 global smartphone manufacturer. This contract allows the customer to utilize...

at 01:05
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. today announced that they have received approval for Kapruvia® from the Swiss Agency for Therapeutic Products (Swissmedic). Kapruvia® will be the first therapy available...

at 01:00
Angel Yeast, (SH600298), a globally listed yeast and yeast extract manufacturer, showcased its latest yeast and yeast extract products, health ingredients, and fermentation ingredients alongside its wide range of innovative solutions at FIC 2022 in...

at 00:52
It has been a rollercoaster couple of years for investors and traders alike - with incredible levels of stimulus resulting in genuine risk taking in financial markets and, of course, multi-decade high inflation. We are all feeling the effects of this...

at 00:00
Together with Tuya Smart , a global IoT development platform service provider, Goodix (603160.SH) has developed a Smart Tag solution that supports Apple's ecology based on the GR551x series Bluetooth Low Energy SoC. Featured with multi-connection,...

18 aoû 2022
Nuance Pharma ("the Company") announces the Center for Drug Evaluation ("CDE") has approved its Investigational New Drug ("IND") application supporting its pivotal clinical trial of Ensifentrine for the maintenance treatment of chronic obstructive...



News published on 21 june 2022 at 13:05 and distributed by: